A routine test. A shocking diagnosis. A new hope – Mary Hylton’s melanoma treatment story with innovative TIL therapy

A Routine Test. A Shocking Diagnosis. A New Hope – Mary Hylton’s Melanoma Treatment Story with Innovative TIL Therapy

Share this

Mary Hylton underwent successful treatment for melanoma at MedStar Health.Mary Hylton was living a joyful life, teaching social work at Salisbury University, raising two adopted daughters with her partner, and walking her dogs. She felt healthy. Nothing seemed wrong.

So when a routine mammogram found small nodules near her left breast, she assumed she was facing breast cancer. “I walked into the next appointment thinking that was what we were dealing with,” Mary says.

Instead, a biopsy showed melanoma, an aggressive skin cancer in her lymph nodes, small glands that help fight infection. Because she had never had a visible skin lesion, the diagnosis was startling. Her doctor sent her to Vinay Gupta, MD, surgical oncologist at MedStar Franklin Square Medical Center, part of the MedStar Georgetown Cancer Institute.

“Meeting Dr. Gupta was the first moment I felt steady again,” Mary says. “He was calm, compassionate, and clear. He helped us understand what was happening and what came next.”

Dr. Gupta performed surgery to remove the melanoma and explained that Mary’s case carried a high risk of recurrence. She then received anti-PD-1 immunotherapy, which helps the immune system recognize and destroy cancer cells and can lower the risk of the cancer returning. About a year later, unfortunately, the cancer had recurred.

That marked a major shift: her melanoma had moved from stage III, when it was limited to nearby lymph nodes, to stage IV, when it had spread to other parts of her body. “That was a hard moment,” Mary says. “I knew how serious stage IV melanoma was.”

Dr. Gupta then referred her to Geoffrey Gibney, MD, co-leader of the Melanoma Disease Group at MedStar Georgetown University Hospital. “I didn’t realize how important it was to see a melanoma specialist,” Mary says. “Looking back, that referral changed everything.”

Doctor Geoffrey Gibney greets patient Mary Hylton at an appointment at MedStar Health.Dr. Gibney started her on combination immunotherapy, the next standard treatment. Her course was complicated by side effects and the cancer did not respond to therapy. As her treatment options narrowed, the cancer continued to grow. She could feel tumors in her breast, abdomen, and thigh. “They were a constant reminder of what was happening,” she says. “I felt weighed down.”

That’s when Dr. Gibney introduced tumor-infiltrating lymphocyte, or TIL, therapy—a treatment that uses a patient’s own immune cells to help fight melanoma. MedStar Georgetown is the first and only health system in the Washington, D.C., region to offer FDA-approved TIL therapy called lifileucel, for metastatic melanoma. 

Lifileucel is a new option for patients whose disease has progressed after anti-PD-1 immunotherapy and if their tumors have a BRAF mutation (a genetic change that can drive cancer growth) after BRAF targeted therapy as well. It provides another therapeutic strategy when these treatments are no longer effective.

To begin TIL therapy, Eleanor Drew, MD, general surgeon and surgical intensivist at Medstar Georgetown, removed a small tumor sample. The cells were then sent to a specialized manufacturing facility where her immune cells were expanded into billions. When the TIL cells were ready, they were returned to her bloodstream, followed by medication to help them work more effectively. “It’s your own immune system, just strengthened,” Mary says.

Throughout her care and recovery, she was guided not only by physicians, but also by compassionate oncology nurses, cellular therapy specialists, and other experts. In the months that followed, that team helped her through one of the hardest stretches of her life. And three months later, scans showed improvement. By her next imaging, the tumors had shrunk even further after just one course of treatment. “That’s when I realized I might actually be getting my life back,” Mary says.

Today, Mary is back to gardening, walking her dogs, teaching, and looking forward to future travels. “For years, I was living and planning at the same time—loving my family while preparing for the worst. Now I get to plan like everyone else.”

Her message to others facing melanoma is simple: “There is more hope than there used to be. Treatments like TIL are changing what’s possible, and the right experts matter more than you realize.”

For more information or for an appointment call 202-993-0492.

Latest patient stories